VRDN Viridian Therapeutics, Inc.

NASDAQ
$31.44

Viridian Therapeutics, Inc. (VRDN) Earnings News

Earnings press releases, previews and reviews for Viridian Therapeutics, Inc. (VRDN), newest first. Our most recent is review: Viridian's Lumvoa Launch Crushes Revenue Expectations, but Thin Disclosure Leaves Durability Questions Open.